WntResearch increases resources for out-licensing of Foxy-5
WntResearch and The Sage Group have initiated a collaboration to accelerate the process of identifying and engaging potential partners prior to readout of the on-going Phase 2 study with Foxy-5.Cancer is by far the largest research area in the pharmaceutical industry and the number of companies focusing on developing and commercializing new cancer treatments amounts to several thousands. In order to increase the visibility of Foxy-5 and engage companies with the right focus and interest in a discussion about a potential future partnership, WntResearch has chosen to start a collaboration